Journal of Medicinal Chemistry · 2007 · 63 citations · 21 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurochemistryNeurodegenerationAlzheimer DiseaseAmyloid FormationBlood-brain Barrier PenetrationBlood-brain Barrier PharmacologyLigand BindingNeuroimaging In DementiaAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid StructureBrain Targeting LigandsFluorescence-based AssaysFluorine-19 Magnetic Resonance Imaging
beta-Amyloid (Abeta) binding affinities and specificities for six bis-styrylbenzenes with multiple magnetically equivalent fluorine atoms in the form of a tetrafluorophenyl core or symmetrical trifluoromethyl and trifluoromethoxy groups were determined by means of fluorescence titrations with amyloid peptide Abeta1-40 and a novel in vitro fluorescence-based assay using APP/PS1 transgenic mouse brain sections. Bis-styrylbenzenes with a tetrafluorophenyl core had increased Abeta binding affinities compared to their monofluorophenyl or phenyl counterparts. Bis-styrylbenzenes with carboxylic acid functional groups had lower Abeta binding affinities than their neutral counterparts. Selected bis-styrylbenzenes were demonstrated to have good blood-brain barrier penetration capabilities. These data extend the SAR of bis-styrylbenzene Abeta binding and provide direction for the development of a noninvasive probe for early detection of Alzheimer's disease using 19F MRI.
21
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Karen Hsiao, Paul F. Chapman, Steven P. Nilsen et al. · Science · 1996 · 4.2K citations
Alzheimer Disease in the US Population
Liesi E. Hebert, Paul A. Scherr, Julia L. Bienias et al. · Archives of Neurology · 2003 · 2.2K citations
Medicine, Geriatric Medicine, Population Health Sciences +17
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Karen Duff, Chris Eckman, Cindy Zehr et al. · Nature · 1996 · 1.5K citations